Soligenix Receives IND Clearance from FDA to Initiate Program Evaluating...
PRINCETON N.J. Jan. 4 2013 PRNewswire &160;Soligenix Inc. OTCQB SNGX Soligenix or the Company a development stage biopharmaceutical company announced today that the Food and Drug Administration FDA...
View ArticleNektar Therapeutics' President and CEO Howard W. Robin To Present at the 31st...
SAN FRANCISCO Jan. 4 2013 PRNewswire &160;Nektar Therapeutics' Nasdaq NKTR President and Chief Executive Officer Howard W. Robin is scheduled to present at the upcoming 31st Annual J.P. Morgan...
View ArticleCrohn's DiseaseGlobal API Manufacturers Marketed and Phase III Drugs...
DelveInsight's Report Crohn's DiseaseGlobal API Manufacturers Marketed and Phase III Drugs Landscape 2016 provides comprehensive insights about the marketed drugs drug sales Phase III pipeline drugs...
View ArticleTNI BioTech Inc. Acquires the Exclusive Rights to Low Dose Naltrexone and...
NEW YORK and BETHESDA Md. Jan. 8 2013 PRNewswire TNI BioTech Inc. PINKSHEETS TNIB announced today that it has signed an agreement for the acquisition of patent rights and orphan drug designation by the...
View ArticleProvention Bio Inc. Secures $28.4 Million Founding Financing to Fund...
LEBANON N.J. June 26 2017 PRNewswire Provention Bio Inc. a recently founded clinicalstage biopharmaceutical company dedicated to sourcing developing and commercializing novel therapeutics aimed at...
View ArticleThe Kenneth Rainin Foundation Announces 2013 Innovator Awards Program $100000...
OAKLAND Calif. Dec. 13 2012 PRNewswireUSNewswire The Kenneth Rainin Foundation announced today its 2013 Innovator Awards Program for Inflammatory Bowel Disease IBD. The Program supports "outofthebox"...
View ArticleAethlon Medical Announces Initiation of CompassionateUse Program to Treat...
SAN DIEGO Dec. 3 2012 PRNewswire &160;Aethlon Medical Inc. OTCBB AEMD the pioneer in developing selective therapeutic filtration devices to address infectious disease cancer and other...
View ArticleMount Sinai Pfizer renew research collaboration building on strong foundation
The Mount Sinai Hospital Mount Sinai School of Medicine The Icahn School of Medicine at Mount Sinai and Pfizer Inc.'s Centers for Therapeutic Innovation CTI today announced the renewal of an agreement...
View ArticleIn the Race for Alternative MOA Biologic in Crohn's Disease Takeda's Entyvio...
EXTON Pa. June 27 2017 PRNewswire Spherix Global Insights has just released the second quarter results of an independent survey regarding the evolving practice patterns in the management of Crohn's...
View ArticleCrohn's disease CD Epidemiology Forecast To 2023 Report Updated 31052017...
DelveInsight Crohn's disease CD Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Crohn's disease CD in seven major markets US France Germany Italy Spain UK and Japan. It...
View ArticleVisceral Pain Market Size to Reach USD 14.22 Billion by 2024 Hexa Research
FELTON California June 27 2017 PRNewswire The global visceral pain market is expected to reach USD 14.22 billion by 2024 driven by the increasing geriatric population globally. Increasing prevalence of...
View ArticleNew OneYear Phase 3 Study Results Show AntiTNF SIMPONIÂ Maintained Clinical...
LAS VEGAS Oct. 22 2012 PRNewswire New Phase 3 study findings showed significantly more patients with moderately to severely active ulcerative colitis UC who responded to induction therapy with...
View ArticleStelara gaining on Entyvio in Crohn's disease survey finds
A recent survey of 103 American gastroenterologists suggests that Stelara has gained in popularity as
View ArticleAlder Biopharmaceuticals Receives $3.5 Million Milestone Payment from...
BOTHELL Wash. Aug. 27 2012 PRNewswire Alder Biopharmaceuticals Inc. today announced it has received a $3.5 million milestone payment from BristolMyers Squibb for the initiation of a Phase 2 clinical...
View ArticlePharmspective Publishes New Assessment of Impact of State Exchanges on Key...
NEW YORK Aug. 22 2012 PRNewswire &160;Pharmspective LLC a market research firm providing syndicated research and knowledge management applications to the pharmaceutical industry today announced the...
View ArticleMacrophage Colony Stimulating Factor 1 Receptor CSF 1 Receptor or Proto...
Macrophage Colony Stimulating Factor 1 Receptor CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1 Pipeline Review H1 2017SummaryMacrophage Colony Stimulating Factor 1 Receptor CSF...
View ArticleLanC Like Protein 2 Testis Specific Adriamycin Sensitivity Protein or G...
LanC Like Protein 2 Testis Specific Adriamycin Sensitivity Protein or G Protein Coupled Receptor 69B or GPR69B or LANCL2 Pipeline Review H1 2017SummaryAccording to the recently published report 'LanC...
View ArticleArena Pharmaceuticals Completes Trial Comparing OnceDaily Extended Release...
SAN DIEGO June 29 2017 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA today announced the completion of a Phase 1 comparative bioavailability study evaluating the pharmacokinetic PK profile of...
View ArticleScientists Spot Genes Behind Crohn's Ulcerative Colitis
THURSDAY June 29 2017 Researchers say they've come closer to pinpointing genes linked with inflammatory bowel diseases such as Crohn's and ulcerative colitis.For the study the investigators examined...
View Article